Full Chain OEM Manufacturing Services for Food Health and Cosmetic Grade Artemisinin Powder

​​​​​​​Through our extensive OEM production services, we provide customized, premium artemisinin powder for use in food, medicine, and cosmetics. Our specialty is the extraction of high-purity artemisinin from Artemisia annua L. while completely adhering to the strict regulations set out by the pharmaceutical and cosmetic industries. With a constant test level of 98–99% purity, our white crystalline powder is used by pharmaceutical companies, producers of health supplements, and cosmetic companies all over the world. By using a factory-direct supply approach, we strike a compromise between cost-effectiveness and strict adherence to ISO9001 and EU certifications, which are essential for gaining access to international markets.

OEM/ODM Excellence in Artemisinin Manufacturing: Beyond Basic Production

We have experience with end-to-end quality control systems, derivative creation, and artemisinin content optimization. We are aware of the particular difficulties faced by health food producers looking for flexible dosage forms and pharmaceutical companies in need of raw ingredients that comply with pharmacopeia. The intricacy of artemisinin manufacturing necessitates cutting-edge biotechnology platforms and industry-university-research cooperation,skills we've honed over years of experience.

To guarantee that every batch artemisinin powder satisfies international standards, such as EU EC396, EU 2023/915 laws, and the most recent USP43 impurity testing criteria, we combine state-of-the-art extraction procedures with stringent testing protocols. Our partners are well-positioned for success in highly regulated industries because to our dedication to compliance.

Our Core OEM/ODM Manufacturing Strengths

Hancuikang has demonstrated proficiency in the production of artemisinin powder with 15 years of specialized knowledge in plant active ingredient development and supply chain management. Core patents in biotechnology and life sciences, such as sophisticated extraction methods, are part of our R&D portfolio and allow us to introduce more than 100 new products a year while upholding strict quality requirements.

Our use of cutting-edge extraction technology is the foundation of our manufacturing expertise. We use supercritical CO₂ extraction, a green method that reduces solvent residues to less than 0.1 ppm, preserves bioavailability, and increases artemisinin purity. From the procurement of raw materials to the final packing, our quality control methods cover the whole manufacturing cycle. Our in-house laboratory supports both pharmaceutical businesses and research institutes by providing thorough HPLC testing and complete analytical results.

Scalability is a major benefit. We can easily handle both large-scale commercial manufacturing requirements and tiny research quantities. With 71–90% of output going to foreign markets in North America, Europe, and Southeast Asia, our worldwide export network spans more than 50 nations. This is consistent with the trend that Chinese suppliers account for 65% of the world's demand for artemisinin raw materials.

What makes us unique is the dependability of our supply chain. We provide adaptable packaging options, such as neutral packaging for brand personalization, and we keep steady inventory levels. Our digital supply chain management technology shortens order delivery cycles to 15 days, which is essential for fulfilling strict market deadlines, and our factory-direct pricing model does away with middlemen.

Advanced Customization for Diverse Artemisinin Applications

Our customization capabilities go far beyond standard artemisinin powder production. We develop tailored formulations optimized for specific use cases: pharmaceutical antimalarial preparations, dietary supplements, and cosmetic ingredients requiring enhanced stability and mildness. This includes adapting to emerging applications like artemisinin’s role in antitumor and immune regulation therapies.

Physical Design Customization

We optimize particle size, select crystal forms, and refine powder flow characteristics to match our clients’ manufacturing processes. Our technical team collaborates closely with partners to develop formulations that enhance bioavailability while maintaining stability under varied storage conditions,addressing a key concern in artemisinin product development.

Functional Customization

We address specific application needs, such as artemisinin powder combination therapy (ACT) formulations, enhanced dissolution profiles, and specialized coating systems for controlled-release applications. Our extraction and purification processes are adaptable to unique specifications, all while maintaining compliance with relevant pharmacopeias. We also explore innovative delivery systems, including encapsulation and sustained-release technologies, to improve stability and minimize resistance concerns.

Packaging, Branding, and Compliance Customization

Packaging flexibility supports our partners’ market positioning strategies. We offer custom sizes from research quantities to commercial bulk containers, alongside private labeling and documentation customization for regulatory submissions. 

The ODM Advantage: Co-Developing Innovative Artemisinin Solutions

Our ODM services turn innovative concepts into market-ready products through collaborative partnerships. We combine extensive R&D capabilities with our clients’ market insights to create differentiated solutions that address specific consumer needs and regulatory demands.

The co-development process starts with comprehensive market analysis and technical feasibility assessments. Our research team evaluates artemisinin pharmacology, optimal dosages, and potential side effects to develop safe, effective formulations. We leverage our understanding of artemisinin’s mechanism of action to enhance therapeutic or cosmetic benefits,including exploring novel applications in anti-aging cosmetics and immune support supplements.

Our Streamlined Manufacturing Process

The journey from concept to market follows a structured, client-centric process:

It begins with detailed consultation to align on requirements, regulatory constraints, and commercial goals. Our technical team then develops optimized manufacturing strategies tailored to these objectives.

Initial development includes raw material selection (sourcing from GAP-certified Artemisia annua L. plantations), extraction optimization, and preliminary stability testing. We utilize advanced isolation techniques to achieve target purity levels while balancing efficiency and cost.

Pilot batch production enables comprehensive testing and refinement before full-scale manufacturing. This phase includes analytical characterization, stability studies, and process validation to ensure consistency and compliance.

Scale-up procedures maintain product quality while meeting commercial volumes. Our quality management systems ensure batch-to-batch consistency, and our supply chain coordination guarantees timely delivery. Post-production support includes ongoing technical assistance, quality monitoring, and regulatory compliance maintenance,critical for long-term market success.

Conclusion

The future of artemisinin applications depends on partnerships with manufacturers that understand both the science and business of this critical compound. Hancuikang combines cutting-edge extraction technology, comprehensive quality systems, and flexible customization to deliver superior results for global partners.

Our commitment extends beyond manufacturing to full supply chain solutions, regulatory support, and ongoing innovation. Whether you need pharmaceutical-grade artemisinin for antimalarial therapies, functional ingredients for health supplements, or specialized formulations for cosmetics, our expertise ensures optimal outcomes.

Leverage our 15 years of experience, extensive global network, and advanced R&D capabilities. Join the growing number of successful brands that trust Hancuikang for their artemisinin powder manufacturing needs,and experience the difference true partnership makes in achieving market success.

Partnering with Hancuikang delivers tangible advantages for business expansion

You gain immediate access to advanced artemisinin production capabilities without heavy capital investment in specialized equipment or expertise. Our established infrastructure and regulatory compliance reduce time-to-market and minimize development risks,key in a market where WHO pre-certification could unlock a 20 billion USD incrementmarket by 2026.

Our extensive testing and certification systems, such as ISO9001:2015, ensure quality assurance. This increases consumer trust by guaranteeing product dependability in a variety of marketplaces.

Our continuous R&D and industry-university-research partnerships provide innovation assistance. We remain on the front edge of technical developments, such as synthetic biology techniques that have the potential to cut production costs by 40% by 2030.

Your success is our priority. We provide dedicated project management and ongoing technical support, drawing on deep expertise in artemisinin production, regulatory compliance, and international market dynamics. Take the next step toward market leadership in artemisinin applications. Contact us at fxu45118@gmail.com to discuss your specific artemisinin powder requirements and discover how our full-chain manufacturing services can accelerate your business growth.

FAQs

Q1: What purity levels can you achieve for artemisinin powder?

A: We consistently produce artemisinin powder with 98-99% assay purity. This is verified through comprehensive HPLC analysis, with detailed certificates of analysis provided for each batch. Our adoption of supercritical CO₂ extraction enables purity levels up to 99.5% for specialized pharmaceutical applications.

Q2: Do you provide regulatory support for international markets?

A: Yes. We offer complete regulatory documentation, including DMF support, stability studies, and compliance certifications for FDA, EMA, WHO, and EU CEP/EDQM requirements. Our team has extensive experience navigating regional regulations, from USP43 standards to EU 2023/915 guidelines.

Q3: What is your minimum order quantity for custom formulations?

A: Our flexible production capabilities accommodate small research batches for development work, scaling up to commercial volumes in 25kg drums or larger custom packaging. We tailor order sizes to meet your specific project phase and market needs.

Q4: How do you ensure supply chain stability for artemisinin raw materials?

A: We source raw materials from GAP-certified Artemisia annua L. plantations in key Chinese producing regions (Yunnan, Hunan, Sichuan). Our digital supply chain management system and FIFO inventory practices ensure consistent stock levels, while our global network includes contingency plans for raw material fluctuations.

Q5: What green production technologies do you use for artemisinin extraction?

A: We utilize supercritical CO₂ extraction, a green technology that reduces solvent residues to below 0.1ppm and lowers unit production capacity and energy consumption by 23% compared to traditional methods. This process aligns with global ESG requirements and EU REACH regulations.

References

1. World Health Organization. "Artemisinin and Artemisinin-based Combination Therapies for Malaria Treatment: Clinical Guidelines and Manufacturing Standards." WHO Technical Report Series, 2023.

2. China Industry Research Institute. "2025-2030 China Artemisinin API Industry Deep Research and Future Sales Channel Trend Report." 2025.

3. International Conference on Harmonisation. "Quality Guidelines for Artemisinin Active Pharmaceutical Ingredients: Manufacturing and Control Standards." ICH Q7 Guidelines, 2022.

4. National Intellectual Property Administration of the People's Republic of China. "A Method for Producing Artemisinin from Chinese Herb Artemisia annua L." Patent Application Publication No. CN 102617591 A, 2012.

5. United States Pharmacopeial Convention. "USP43-NF38 S1: Artemisinin Quality Standards." 2024.